Developer docs
API playgroundTry for free, no card

Search company profiles

Oystershell laboratories

Full company profile

uuid000g7mn

Namestring
Oystershell laboratories
Legal namestring
Oystershell
Websiteurl
oystershell.com
Company typeenum
Private
Founded yearint
1979
Descriptiontext

Oystershell Laboratories is a Belgium-headquartered consumer health product developer founded in 1979 that pivoted from its original oyster-shell calcium supply business to self-medication and dermatology products following a 2002 management buyout led by bioengineer Bart Rossel. The company operates two units: Oystershell Consumer Health, which markets four own brands (RID in the USA, Elimax, Pistal, Nvive, and Ultractive) in lice treatment, insect protection, digestive health, and women's wellness; and Oystershell Laboratories, a B2B contract-development business that develops product innovations for more than 30 leading consumer healthcare companies and licenses finished-product IP to be commercialized under customer-owned brands in over 80 countries.

The technology backbone rests on a portfolio of patented proprietary platforms rather than a single dominant product: the LiquiShell delivery format (a chewable shell with a liquid core that enables fast absorption and high liquid loading, applied across OTC and VMS), the LPF (Licensed Protection Factor) lice-protection technology used in Elimax, the ClearWick anti-clog wick in Pistal diffusers, and a cryogenic device technology positioned as the world's first safe at-home wart treatment that achieves lower temperatures than traditional propane/ether devices. These innovations are paired with a #1 market position in lice treatment in the USA and a #1 position in cryogenic wart treatment globally, supported by a regulatory dossier depth that yields 3–4 year development cycles for new medical devices.

The business model is asset-light: manufacturing is outsourced to contract producers overseen by Oystershell's supply chain team, while R&D, regulatory, quality, IP, and brand marketing are retained in-house. Revenue is generated through three streams — own-brand product sales via distributors, online pharmacies, Amazon, and an Ultractive webshop in core territories (Belgium, USA, Austria, Portugal); licensing royalties and finished-product supply agreements with 30+ healthcare customers; and managed-services supply chain oversight. The company has been majority-owned by private equity firm Rivean Capital (formerly Gilde) since a 2017 controlling-stake acquisition.

Short descriptiontext

Oystershell Laboratories is a Belgian consumer health company that develops and markets innovative self-medication products through two units: own-brand Consumer Health (RID, Elimax, Pistal, Nvive, Ultractive) and a B2B Laboratories arm licensing 30+ product innovations to healthcare companies across 80+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersMerelbeke, Belgium
HQ citystring
Merelbeke
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
consumer healthcare products, lice treatment products, dermatology treatments, nutritional supplements, private label manufacturing
Industry5 codes
PRIMARYCRADAGAC
Multivitamins & Daily Packs
SECONDARYCRADAGAF
Probiotics & Digestive Health Supplements
SECONDARYCRADAGAB
Vitamins & Minerals (Single Nutrients)
SECONDARYCRADAAAI
Specialty & Functional Packaged Foods (Gluten-Free, Keto, Organic, Medical/Allergen-Friendly)
SECONDARYHLAIAJAC
OTC & Consumer Health Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Consumer Healthcare
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Own Brand Product Sales
TypeOne Time License
Description

Oystershell Consumer Health markets four category-leading brands (RID, Elimax, Pistal, Nvive) in core territories (USA, Belgium, Austria, Portugal). Revenue generated from direct sales of consumer health products through distributors, online pharmacies, Amazon, and own webshop.

oystershell.com
2Licensing and Supply Agreements
TypeLicensing Royalties
Description

Oystershell Laboratories develops product innovations for third-party healthcare companies. New product developments result in agreements on licensing out the IP and supplying finished products to customers. Over 30 long-term healthcare company customers commercialize products under their own brands in over 80 countries.

oystershell.com
3Contract Manufacturing Oversight
TypeManaged Services
Description

Asset-light model combining own know-how and technologies with outsourced manufacturing. Best-in-class contract manufacturers produce products, overseen by Oystershell's supply chain team.

oystershell.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Marketing or Sales, Personnel, Operations, Supply Chain, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1RID
Description

America's #1 Lice Brand Equity. Products include RID Super Max (pesticide-free lice treatment), RID Pure Power (100% natural lice treatment), and RID Daily Defense (everyday shampoo and conditioner for lice defense).

oystershell.com
+5 more records
Core offering1 text field

Oystershell Laboratories develops and markets innovative consumer healthcare products across dermatology, lice and insect treatment, and nutritional supplements. The company operates two units: Consumer Health markets its own brands (RID, Elimax, Pistal, Nvive, Ultractive) directly to consumers through pharmacies, online pharmacies, Amazon, and its own webshop, while Laboratories develops product innovations, licenses IP, and supplies finished products to more than 30 third-party healthcare companies commercializing under their own brands in over 80 countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 100% effective lice and nit elimination with single 5-minute treatment
+4 more records
Product overview1 text field

Oystershell Laboratories is a consumer health company operating two distinct business units: Oystershell Consumer Health markets four category-leading brands (RID, Elimax, Pistal, Nvive) in lice treatment, insect protection, and digestive health, while Oystershell Laboratories develops and licenses innovative products (lice treatments, wart treatments, nail fungus treatments, wound healing) to third-party healthcare companies. The company owns the proprietary LiquiShell technology platform, a center-filled gummy delivery format combining liquid cores with chewable shells, which is used in Nvive and available for licensing to partners. Products are marketed in over 80 countries through both Oystershell's own brands and customer-owned brands under licensing agreements.

Product and service7 records
1RID
CategoryOwn Brand - Lice Treatment
Description

America's #1 lice treatment brand featuring pesticide-free formulations. The product line includes RID Super Max (a 5-in-1 complete kit with 24/7 lice defense), RID Pure Power (first 100% natural lice treatment effective against super lice and eggs), and RID Daily Defense (gentle everyday shampoo and conditioner providing 24/7 lice defense). Targeted at US consumers and families needing OTC lice treatment.

2Elimax
CategoryOwn Brand - Lice Treatment
Description

Lice treatment brand using world-leading technology that is 100% effective against lice and nits without insecticides or silicones. Features patented LPF technology that protects against re-infestation for up to 3 days. Includes Elimax Natural Lotion based on exclusively natural ingredients. Targeted at European consumers and families needing OTC lice treatment.

3Pistal
CategoryOwn Brand - Insect Protection
Description

Insect and microorganism protection brand based on plant-based ingredients with proven efficacy. Product range includes insect sprays, the Pistal Mosquito plug-in diffuser with ClearWick technology, and Pistal Air Purifier. Targeted at consumers seeking natural, plant-based insect protection for families.

4Nvive
CategoryOwn Brand - Digestive Health
Description

First LiquiShell-powered product under Oystershell's own brand. Nvive is a liquid-filled gummy combining a liquid ginger core with a chewable outer shell for rapid relief from digestive discomfort, travel-related nausea, and mild indigestion, using highly concentrated gingerol extract. Targeted at Belgian consumers seeking fast-acting digestive support.

5Ultractive
CategoryOwn Brand - Women's Nutritional Supplements
Description

Women's wellness nutritional supplement brand offering benefits from stress relief to improved memory. Products include Ultractive Magnesium, Lights Out sleep aid, and Multi Boost vitality and resistance supplement. Distribution is online-first via online pharmacies and the Ultractive webshop, targeting women in Belgium seeking stress relief, better sleep, memory support, and vitality.

6LiquiShell
CategoryProprietary Technology Platform
Description

Proprietary oral dosage delivery format featuring a chewable shell with a liquid core. Merges benefits of liquid and solid dosage forms, enabling fast absorption, protection of heat-sensitive actives, and unusually high liquid loading. Fully customizable in flavor, color, and ingredients. Vegan and supports both OTC and VMS (vitamins, minerals, supplements) applications. Available for licensing to healthcare companies.

7Oystershell Laboratories Contract Development and Licensing
CategoryB2B Licensing and Supply Services
Description

B2B contract development service for third-party healthcare companies. Oystershell develops product innovations, licenses IP, and supplies finished products under customer-owned brands. Portfolio includes lice treatments, cryogenic wart treatments, nail fungus treatments, and wound healing products marketed in over 80 countries through 30+ long-term healthcare company customers.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeOthers
Description

Long-term partnerships with best-in-class contract manufacturers for the production of products. Oystershell outsources production which is overseen by their supply chain team. Oystershell manages and pays contractors while retaining all intellectual property and patents.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Over 30 leading consumer healthcare companies partner with Oystershell Laboratories for product innovation. These customers commercialize Oystershell's product innovations under their own brands through licensing and supply agreements. Products are marketed in over 80 countries.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Local distributors and service providers implement marketing, sales and logistics strategy for Consumer Health products in core territories (USA, Belgium, Austria, Portugal).

Strategic tierMinorTypeGTM or Marketing Partner
Description

Sponsored Nerdland podcast episodes to reach science-curious audiences. CEO Bart Rossel appeared on podcast and co-authored book 'How Do You Make That?' featured on the show.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Spun out of GSK as a pure-play consumer health company spanning OTC, oral care and vitamins. Highly comparable as a global consumer-health brand owner serving pharmacy and retail channels, though much larger and broader than Oystershell.

TypeBroad incumbent
Description

US-listed consumer health and household products company with a portfolio of category-leading brands sold through mass and pharmacy channels. Comparable as a multi-brand OTC/consumer health operator and as the former owner of the RID brand that Oystershell acquired in 2020.

TypeBroad incumbent
Description

Specializes in OTC self-care products and store-brand (private label) consumer healthcare, including through its Omega Pharma subsidiary in Europe. Comparable business model of OTC development plus distribution across European pharmacy channels, similar to Oystershell's licensing-plus-own-brand approach.

TypeDirect peer
Description

US-listed acquirer and marketer of OTC consumer healthcare brands across categories including personal care and dermatology. Highly comparable as a roll-up operator of niche OTC brands — similar strategic logic to Oystershell's own-brand-plus-licensing model.

5Bayer Consumer Health
TypeBroad incumbent
Description

Division of Bayer focused on OTC and consumer health products across dermatology, pain, and nutrition in global markets. Comparable as a global consumer health brand owner in OTC and self-care categories where Oystershell competes with own brands and licenses innovations to partners.

TypeDirect peer
Description

European OTC specialist in women's health, dermatology and self-care, now part of Perrigo. Comparable in focus on niche OTC product development and licensing across European pharmacy channels, similar to Oystershell Laboratories' B2B innovation model.

TypeBroad incumbent
Description

Global consumer health and hygiene company behind brands like Nurofen, Gaviscon and Durex. Comparable as a global OTC brand owner with strong pharmacy and retail presence and active M&A history in consumer health.

TypeDirect peer
Description

Belgian-based OTC and personal care company now owned by Perrigo. Direct regional peer given shared Belgian HQ region and European pharmacy-channel distribution model used by Oystershell's own-brand business.

TypeDirect peer
Description

European specialty pharmaceutical company focused on dermatology and self-care. Comparable as a Europe-based developer and marketer of dermatology/OTC products, overlapping with Oystershell's Elimax and Pistal categories.

TypeBroad incumbent
Description

Global consumer products company with a leading insect repellent portfolio (e.g. OFF!). Comparable as a competitor in the consumer insect-protection category where Oystershell's Pistal brand operates, though SC Johnson is far larger and broader in scope.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Oystershell laboratories

Consumer Healthcareoystershell.com

Oystershell Laboratories is a Belgian consumer health company that develops and markets innovative self-medication products through two units: own-brand Consumer Health (RID, Elimax, Pistal, Nvive, Ultractive) and a B2B Laboratories arm licensing 30+ product innovations to healthcare companies across 80+ countries.

What Oystershell laboratories does

Oystershell Laboratories is a Belgium-headquartered consumer health product developer founded in 1979 that pivoted from its original oyster-shell calcium supply business to self-medication and dermatology products following a 2002 management buyout led by bioengineer Bart Rossel. The company operates two units: Oystershell Consumer Health, which markets four own brands (RID in the USA, Elimax, Pistal, Nvive, and Ultractive) in lice treatment, insect protection, digestive health, and women's wellness; and Oystershell Laboratories, a B2B contract-development business that develops product innovations for more than 30 leading consumer healthcare companies and licenses finished-product IP to be commercialized under customer-owned brands in over 80 countries.

The technology backbone rests on a portfolio of patented proprietary platforms rather than a single dominant product: the LiquiShell delivery format (a chewable shell with a liquid core that enables fast absorption and high liquid loading, applied across OTC and VMS), the LPF (Licensed Protection Factor) lice-protection technology used in Elimax, the ClearWick anti-clog wick in Pistal diffusers, and a cryogenic device technology positioned as the world's first safe at-home wart treatment that achieves lower temperatures than traditional propane/ether devices. These innovations are paired with a #1 market position in lice treatment in the USA and a #1 position in cryogenic wart treatment globally, supported by a regulatory dossier depth that yields 3–4 year development cycles for new medical devices.

The business model is asset-light: manufacturing is outsourced to contract producers overseen by Oystershell's supply chain team, while R&D, regulatory, quality, IP, and brand marketing are retained in-house. Revenue is generated through three streams — own-brand product sales via distributors, online pharmacies, Amazon, and an Ultractive webshop in core territories (Belgium, USA, Austria, Portugal); licensing royalties and finished-product supply agreements with 30+ healthcare customers; and managed-services supply chain oversight. The company has been majority-owned by private equity firm Rivean Capital (formerly Gilde) since a 2017 controlling-stake acquisition.

Oystershell laboratories firmographics

Firmographics
Name
Oystershell laboratories
Legal name
Oystershell
Website
https://oystershell.com
Company type
Private
Founded year
1979
Operating status
Operating
Headcount range
51–100 employees
Short description
Oystershell Laboratories is a Belgian consumer health company that develops and markets innovative self-medication products through two units: own-brand Consumer Health (RID, Elimax, Pistal, Nvive, Ultractive) and a B2B Laboratories arm licensing 30+ product innovations to healthcare companies across 80+ countries.
Ownership category
akta.pro rank

Oystershell laboratories industry classification

Industry
Product category
Consumer Healthcare
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYCRADAGAC
Multivitamins & Daily Packs
SECONDARYCRADAGAF
Probiotics & Digestive Health Supplements
SECONDARYCRADAGAB
Vitamins & Minerals (Single Nutrients)
SECONDARYCRADAAAI
Specialty & Functional Packaged Foods (Gluten-Free, Keto, Organic, Medical/Allergen-Friendly)
SECONDARYHLAIAJAC
OTC & Consumer Health Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling

Keywords

  • Consumer healthcare products
  • Lice treatment products
  • Dermatology treatments
  • Nutritional supplements
  • Private label manufacturing

Where Oystershell laboratories is headquartered

Location

Headquarters

HQ city
Merelbeke
HQ country
Belgium
HQ region
Europe

Offices2 records

Markets served

Oystershell laboratories business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Marketing or Sales, Personnel, Operations, Supply Chain, Infrastructure

Revenue model

  1. Own Brand Product Sales: Oystershell Consumer Health markets four category-leading brands (RID, Elimax, Pistal, Nvive) in core territories (USA, Belgium, Austria, Portugal). Revenue generated from direct sales of consumer health products through distributors, online pharmacies, Amazon, and own webshop.
  2. Licensing and Supply Agreements: Oystershell Laboratories develops product innovations for third-party healthcare companies. New product developments result in agreements on licensing out the IP and supplying finished products to customers. Over 30 long-term healthcare company customers commercialize products under their own brands in over 80 countries.
  3. Contract Manufacturing Oversight: Asset-light model combining own know-how and technologies with outsourced manufacturing. Best-in-class contract manufacturers produce products, overseen by Oystershell's supply chain team.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Oystershell laboratories product offering

Product offering

Core offering

Oystershell Laboratories develops and markets innovative consumer healthcare products across dermatology, lice and insect treatment, and nutritional supplements. The company operates two units: Consumer Health markets its own brands (RID, Elimax, Pistal, Nvive, Ultractive) directly to consumers through pharmacies, online pharmacies, Amazon, and its own webshop, while Laboratories develops product innovations, licenses IP, and supplies finished products to more than 30 third-party healthcare companies commercializing under their own brands in over 80 countries.

Product overview

Oystershell Laboratories is a consumer health company operating two distinct business units: Oystershell Consumer Health markets four category-leading brands (RID, Elimax, Pistal, Nvive) in lice treatment, insect protection, and digestive health, while Oystershell Laboratories develops and licenses innovative products (lice treatments, wart treatments, nail fungus treatments, wound healing) to third-party healthcare companies. The company owns the proprietary LiquiShell technology platform, a center-filled gummy delivery format combining liquid cores with chewable shells, which is used in Nvive and available for licensing to partners. Products are marketed in over 80 countries through both Oystershell's own brands and customer-owned brands under licensing agreements.

Differentiator

Problem solved

Functional benefit

Brands

  • RID: America's #1 Lice Brand Equity. Products include RID Super Max (pesticide-free lice treatment), RID Pure Power (100% natural lice treatment), and RID Daily Defense (everyday shampoo and conditioner for lice defense).
  • Elimax
  • Pistal
  • Ultractive
  • Nvive
  • LiquiShell

Products and services

  • RID America's #1 lice treatment brand featuring pesticide-free formulations. The product line includes RID Super Max (a 5-in-1 complete kit with 24/7 lice defense), RID Pure Power (first 100% natural lice treatment effective against super lice and eggs), and RID Daily Defense (gentle everyday shampoo and conditioner providing 24/7 lice defense). Targeted at US consumers and families needing OTC lice treatment.
  • Elimax Lice treatment brand using world-leading technology that is 100% effective against lice and nits without insecticides or silicones. Features patented LPF technology that protects against re-infestation for up to 3 days. Includes Elimax Natural Lotion based on exclusively natural ingredients. Targeted at European consumers and families needing OTC lice treatment.
  • Pistal Insect and microorganism protection brand based on plant-based ingredients with proven efficacy. Product range includes insect sprays, the Pistal Mosquito plug-in diffuser with ClearWick technology, and Pistal Air Purifier. Targeted at consumers seeking natural, plant-based insect protection for families.
  • Nvive First LiquiShell-powered product under Oystershell's own brand. Nvive is a liquid-filled gummy combining a liquid ginger core with a chewable outer shell for rapid relief from digestive discomfort, travel-related nausea, and mild indigestion, using highly concentrated gingerol extract. Targeted at Belgian consumers seeking fast-acting digestive support.
  • Ultractive Women's wellness nutritional supplement brand offering benefits from stress relief to improved memory. Products include Ultractive Magnesium, Lights Out sleep aid, and Multi Boost vitality and resistance supplement. Distribution is online-first via online pharmacies and the Ultractive webshop, targeting women in Belgium seeking stress relief, better sleep, memory support, and vitality.
  • LiquiShell Proprietary oral dosage delivery format featuring a chewable shell with a liquid core. Merges benefits of liquid and solid dosage forms, enabling fast absorption, protection of heat-sensitive actives, and unusually high liquid loading. Fully customizable in flavor, color, and ingredients. Vegan and supports both OTC and VMS (vitamins, minerals, supplements) applications. Available for licensing to healthcare companies.
  • Oystershell Laboratories Contract Development and Licensing B2B contract development service for third-party healthcare companies. Oystershell develops product innovations, licenses IP, and supplies finished products under customer-owned brands. Portfolio includes lice treatments, cryogenic wart treatments, nail fungus treatments, and wound healing products marketed in over 80 countries through 30+ long-term healthcare company customers.

Quantifiable outcome

  • 100% effective lice and nit elimination with single 5-minute treatment
  • +4 more outcomes

Companies that use Oystershell laboratories

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Oystershell laboratories technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Oystershell laboratories partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Contract ManufacturerscoreOthersLong-term partnerships with best-in-class contract manufacturers for the production of products. Oystershell outsources production which is overseen by their supply chain team. Oystershell manages and pays contractors while retaining all intellectual property and patents.
  • Consumer Healthcare CompaniescoreStrategic or Co-development PartnerOver 30 leading consumer healthcare companies partner with Oystershell Laboratories for product innovation. These customers commercialize Oystershell's product innovations under their own brands through licensing and supply agreements. Products are marketed in over 80 countries.
  • Distributors and Service ProvidersminorChannel Partner/ Reseller/ DistributorLocal distributors and service providers implement marketing, sales and logistics strategy for Consumer Health products in core territories (USA, Belgium, Austria, Portugal).
  • Nerdland PodcastminorGTM or Marketing PartnerSponsored Nerdland podcast episodes to reach science-curious audiences. CEO Bart Rossel appeared on podcast and co-authored book 'How Do You Make That?' featured on the show.

Scale indicators7 records

Recent moves8 records

Expansion highlights6 records

Oystershell laboratories competitors and assessment

Company assessment

Broad incumbents

  • Haleon: Spun out of GSK as a pure-play consumer health company spanning OTC, oral care and vitamins. Highly comparable as a global consumer-health brand owner serving pharmacy and retail channels, though much larger and broader than Oystershell.
  • Church & Dwight: US-listed consumer health and household products company with a portfolio of category-leading brands sold through mass and pharmacy channels. Comparable as a multi-brand OTC/consumer health operator and as the former owner of the RID brand that Oystershell acquired in 2020.
  • Perrigo Company: Specializes in OTC self-care products and store-brand (private label) consumer healthcare, including through its Omega Pharma subsidiary in Europe. Comparable business model of OTC development plus distribution across European pharmacy channels, similar to Oystershell's licensing-plus-own-brand approach.
  • Bayer Consumer Health: Division of Bayer focused on OTC and consumer health products across dermatology, pain, and nutrition in global markets. Comparable as a global consumer health brand owner in OTC and self-care categories where Oystershell competes with own brands and licenses innovations to partners.
  • Reckitt Benckiser: Global consumer health and hygiene company behind brands like Nurofen, Gaviscon and Durex. Comparable as a global OTC brand owner with strong pharmacy and retail presence and active M&A history in consumer health.
  • SC Johnson: Global consumer products company with a leading insect repellent portfolio (e.g. OFF!). Comparable as a competitor in the consumer insect-protection category where Oystershell's Pistal brand operates, though SC Johnson is far larger and broader in scope.

Direct peers

  • Prestige Consumer Healthcare: US-listed acquirer and marketer of OTC consumer healthcare brands across categories including personal care and dermatology. Highly comparable as a roll-up operator of niche OTC brands — similar strategic logic to Oystershell's own-brand-plus-licensing model.
  • HRA Pharma (Perrigo): European OTC specialist in women's health, dermatology and self-care, now part of Perrigo. Comparable in focus on niche OTC product development and licensing across European pharmacy channels, similar to Oystershell Laboratories' B2B innovation model.
  • Omega Pharma (Perrigo): Belgian-based OTC and personal care company now owned by Perrigo. Direct regional peer given shared Belgian HQ region and European pharmacy-channel distribution model used by Oystershell's own-brand business.
  • Almirall: European specialty pharmaceutical company focused on dermatology and self-care. Comparable as a Europe-based developer and marketer of dermatology/OTC products, overlapping with Oystershell's Elimax and Pistal categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Oystershell laboratories social profiles

Digital presence

Oystershell laboratories financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Oystershell laboratories leadership team

Management profile

Number of profiles

Profiles2 records

Oystershell laboratories funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Oystershell laboratories M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oystershell laboratories

What does Oystershell laboratories do?

Oystershell Laboratories develops and markets innovative consumer healthcare products across dermatology, lice and insect treatment, and nutritional supplements. The company operates two units: Consumer Health markets its own brands (RID, Elimax, Pistal, Nvive, Ultractive) directly to consumers through pharmacies, online pharmacies, Amazon, and its own webshop, while Laboratories develops product innovations, licenses IP, and supplies finished products to more than 30 third-party healthcare companies commercializing under their own brands in over 80 countries.

Is Oystershell laboratories a public or private company?

Oystershell laboratories is a private company. It is classified as private equity controlled and is currently operating.

When was Oystershell laboratories founded?

Oystershell laboratories was founded in 1979. It employs 51 to 100 people.

Where is Oystershell laboratories based?

Oystershell laboratories is headquartered in Merelbeke, Belgium, in the Europe region.

How does Oystershell laboratories make money?

Three revenue lines are on record. Own Brand Product Sales are the primary driver. The others are licensing and Supply Agreements and contract Manufacturing Oversight.

Who are Oystershell laboratories's main competitors?

Broad incumbents on record are Haleon, Church & Dwight, Perrigo Company, Bayer Consumer Health, Reckitt Benckiser and SC Johnson. Direct peers are Prestige Consumer Healthcare, HRA Pharma (Perrigo), Omega Pharma (Perrigo) and Almirall.

Does Oystershell laboratories have an API?

No public API is recorded for Oystershell laboratories.

What industry is Oystershell laboratories in?

Oystershell laboratories's product category is Consumer Healthcare. Its primary akta.pro industry code is CRADAGAC, Multivitamins & Daily Packs, with a secondary code of CRADAGAF, Probiotics & Digestive Health Supplements. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales